heart failure

Shakil SS, Hsue PY. Heart Failure Risk in HIV: From Immunodeficiency to Metabolic Complexity. Circ Heart Fail. 2026 Mar 11:e014088. doi: 10.1161/CIRCHEARTFAILURE.126.014088. Epub ahead of[...]

By afschroeder • March 12, 2026

Yin Y, Morgan CJ, Costello RB, Fonarow GC, Cheng Y, Tekle S, Faselis C, Lam PH, Sheriff HM, Rosanoff A, Anker SD, Raman VK, Moore[...]

By afschroeder • March 10, 2026

Siddiqi TJ, Khan MS, Fonarow GC, Butler J, Greene SJ. Reply to commentary on 'effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and[...]

By afschroeder • March 3, 2026

Qadri N, Kwok E, Stanberry L, Thomas C, Irausquin SJ, Gupta D, Ebinger JE, Gluckman TJ, Mutharasan RK, Goyal A, Brownell NK, Scirica BM, Ho[...]

By afschroeder • February 27, 2026

Ahmed M, Zulfiqar E, Hashmi TM, Zia R, Ashraf H, Naveed MA, Ahmed R, Rana JS, Ahmed F, Greene SJ, Fudim M, Mentz RJ, Fonarow[...]

By afschroeder • February 20, 2026

DeVore AD, Majmudar M, Etters L, Xie J, Hao C, Lam PH, Hernandez AF, Fonarow GC, Desai AS. Digital Platform to Optimize Guideline-Directed Heart Failure[...]

By afschroeder • February 18, 2026

Nguyen XT, Elhouderi E, Li Y, Williams AR, Gaziano L, Joseph J, Gaziano JM, Cho K, Djousse L; VA Million Veteran Program. Alcohol Intake and[...]

By afschroeder • February 13, 2026

Greene SJ, Xu H, Chiswell K, Felker GM, Lewsey SC, Divanji PH, Goertz HP, Heitner SB, Butler J, Fonarow GC. Residual Risk Despite Quadruple Medical[...]

By afschroeder • February 3, 2026

Khalid A, Balach R, Rasool A, Daniyal SM, Nizami MT, Gul I, Naqvi A, Fonarow GC, Waqas SA. Clinical outcomes and safety of SGLT2 inhibitors[...]

By afschroeder • January 17, 2026

Abel ED, Ahima RS, Anderson EJ, Berg DD, Berger JS, Das S, Feinberg MW, Fisher EA, Garshick MS, Giannarelli C, Goldberg IJ, Hamburg NM, Kim[...]

By afschroeder • January 16, 2026